¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"È¿"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
leukocytic ferment
¹éÇ÷±¸ºÐÇØ¹ßÈ¿¼Ò
ligase
¿¬°áÈ¿¼Ò, ¶óÀ̰ÔÀ̽º
lipase
ÁöÁúºÐÇØÈ¿¼Ò, ¸®ÆÄÁ¦
lipoclastic enzyme
ÁöÁúºÐÇØÈ¿¼Ò
lipolytic enzyme
ÁöÁúºÐÇØÈ¿¼Ò
lipoprotein lipase
ÁöÁú´Ü¹éÁöÁúºÐÇØÈ¿¼Ò
lipoxidase
Áö¹æ»êÈÈ¿¼Ò, ¸®Æø½Ã´ÙÁ¦
lactase
Á¥´çºÐÇØÈ¿¼Ò, ¶ôŸ¾ÆÁ¦
lactate dehydrogenase
Á¥»êÅ»¼ö¼ÒÈ¿¼Ò, LDH
living ferment
»ý¹°¹ßÈ¿¼Ò
low potency
1. ÀúÈ¿´É, Àú¿ª°¡ 2. ÀúÀáÀç·Â
lyase
ºÐÇØÈ¿¼Ò, ¶óÀÌ¿¡À̽º
lysozyme
¿ë±ÕÈ¿¼Ò, ¶óÀ̼ÒÀÚÀÓ
milk fermentation
Á¥¹ßÈ¿
minimal effective analgesic concentration
ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
shunt effect
Áö¸§±æÈ¿°ú, ¼ÇƮȿ°ú
sialagogic effect
ħºÐºñÃËÁøÈ¿°ú
signal effect
½Åȣȿ°ú
spin phase effect
½ºÇÉÀ§»óÈ¿°ú
splitting enzyme
ºÐ¸®È¿¼Ò
steatolytic enzyme
Áö¹æºÐÇØÈ¿¼Ò
stochastic effect
È®·ü·ÐÀûÈ¿°ú
suction effect
Èí¼öÈ¿°ú
summation effect
°¡ÁßÈ¿°ú
synergistic effect
»ó½ÂÈ¿°ú
thermal efficiency
¿È¿À²
toxic effect
Áßµ¶È¿°ú, Áßµ¶ÀÛ¿ë
trapdoor effect
¶Ñ²±¹®È¿°ú
uricolytic enzyme
¿ä»êºÐÇØÈ¿¼Ò
visual efficiency
½Ã°¢È¿À²
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
immunoperoxidase
¸é¿ª°ú»êÈÈ¿¼Ò
immunoperoxidase test
¸é¿ª°ú»êÈÈ¿¼Ò½ÃÇè
in-flow effect
À¯ÀÔ È¿°ú
indophenol oxidase
ÀεµÆä³î»êÈÈ¿¼Ò.
induced enzyme
À¯µµÈ¿¼Ò.
inducible enzyme
À¯µµ(¹ß)È¿¼Ò.
inducible enzyme
À¯¹ß°¡´ÉÈ¿¼Ò
ineffective dose
¹«È¿·®(ÙíüùåÖ).
ineffective erythropoiesis
¹«È¿Á¶Ç÷.
ineffective erythropoiesis
¹«È¿Á¶Ç÷.
inhibitory effect
¾ïÁ¦È¿°ú(åäð¤ Íý).
inhibitory effect
¾ïÁ¦È¿°ú.
inhibitory enzyme
ÀúÇØÈ¿¼Ò.
inorganic enzyme
¹«±âÈ¿¼Ò(ÙíѦý£áÈ).
inorganic ferment
¹«±âÈ¿¸ð(ÙíѦý£Ù½).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
dopamine autoreceptor agonist
µµÆÄ¹Î ÀÚ°¡¼ö¿ëü È¿ÇöÁ¦
doppler effect
µµÇ÷¯ È¿°ú (üùÍý)
dose rate effect
¼±·®À²È¿°ú
double effect
ÀÌÁßÈ¿°ú
dried yeast
°ÇÁ¶È¿¸ð(ËëðÏý£Ù½).
drug effect
¾à¹°È¿°ú
dry tap
¹«È¿ÃµÀÚ(Ùíüùô¾ô§).
drying effect
°ÇÁ¶È¿°ú(ËëðÏüùÍý).
dual block action
ÀÌ»ó¼º Â÷´ÜÈ¿°ú.
dual effect
ÀÌ»ó¼º(ÀÌÁß)È¿°ú.
dual effect
ÀÌ»ó¼º(ì¶ßÒàõ)(ÀÌÁß)È¿°ú.
early effect
Á¶±âÈ¿°ú
ectoenzyme
¿¢ÅäÈ¿¼Ò.
edge effect
¿¬È¿°ú(æÞüùÍý).
edge effect
¸ð¼¸®È¿°ú
ÀÌÀü
´ÙÀ½
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
protein efficiency ratio
´Ü¹éÁú(Ó±ÛÜòõ) È¿À²ºñ(üù×ËÝï)
protein efficiency ratio method
´Ü¹éÁú(Ó±ÛÜòõ) È¿À²ºñ¹ý(üù×ËÝïÛö)
protein kinase
"´Ü¹éÁú(Ó±ÛÜòõ) Ä«À̳×À̽º, ´Ü¹éÁú(Ó±ÛÜòõ) Ȱ¼ºÈÈ¿¼Ò(üÀàõûùý£áÈ)"
proteolytic enzyme
´Ü¹éÁú °¡¼öºÐÇØ È¿¼Ò(Ó±ÛÜòõÊ¥â©ÝÂú°ý£áÈ)
protoenzyme
¿ø½ÃÈ¿¼Ò(ê«ã·ý£áÈ)
proximity effect
±ÙÁ¢È¿°ú(ÐÎïÈüùÍý)
pseudoisoenzyme
À§(êÊ)À̼ÒÈ¿¼Ò(ý£áÈ)
pyridine nucleotide coenzymes
ÇǸ®µò ´©Å¬·¹¿ÀŸÀÌµå º¸È¿¼Ò(ÜÍý£áÈ)
Q-enzyme
Q È¿¼Ò(ý£áÈ)
quantum efficiency
¾çÀÚ È¿À²(åÕíüù×Ë)
radioautographic efficiency
¹æ»ç¼± ÀÚµ¿»çÁø È¿À²(Û¯ÞÒàÊí»ÔÑÞÐòØüù×Ë)
radioisotopic enzyme assay
¹æ»ç¼º µ¿À§¿ø¼Ò È¿¼Ò(Û¯ÞÒàõÔÒêÈêªáÈý£áÈ) ¾Æ½êÀÌ
Raman effect
¶ó¸¸ È¿°ú(üùÍý)
reactive enzyme centrifugetion
¹ÝÀÀÈ¿¼Ò ¿ø½ÉºÐ¸®(Úãëëý£áÈêÀãýÝÂ×î)
recBCD enzyme
recBCD È¿¼Ò(ý£áÈ)
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
¼³¸í
sedative effect
ÁøÁ¤ È¿°ú
sensory effect
°¨°¢ È¿°ú
seroenzyme
Ç÷û È¿¼Ò
shearing effect
Àü´Ü È¿°ú
short acting insulin
¼ÓÈ¿¼º Àν¶¸°
sialogogic effect
Ÿ¾× ºÐºñ ÃËÁø È¿°ú
siphonage effect
½ÎÀÌÆù È¿°ú
snow-storm effect
´«º¸¶ó È¿°ú
somogyi effect
¼Ò¸ð±â È¿°ú
Á¦ 1Çü ´ç´¢º´ ȯÀÚ¿¡¼ ¾ß°£¿¡ ÀúÇ÷´çÁõÀÌ ¹ß»ýÇÏ´Â °æ¿ì ±æÇ× Á¶Àý È£¸£¸óÀÇ ºÐºñ¸¦ ÀÚ±ØÇÏ¿©
spin phase effect
½ºÇÉ À§»ó È¿°ú
splitting enzyme
ºÐÇÒ È¿¼Ò
stereoeffect
ÀÔü È¿°ú
stochastic effect
È®·üÀû È¿°ú
suction effect
ÈíÀÔ È¿°ú
suffing effect
À̿ ¸ÅÀÔ È¿°ú
À̿ ±³È¯¿¡ ÀÇÇÑ µµÀçÀÇ °È È¿°ú.
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
inefficiency
ºñ´É·ü;¹«´É;¹«È¿·Â;ºñ´É·üÀûÀΰÍ
inefficient
(»ç¶÷ÀÌ)¹«´ÉÇÑ;(»ç¹°ÀÌ)È¿·Â(È¿°ú)ÀÌ ¾ø´Â;(±â°èµîÀÌ)ºñ´É·üÀûÀÎ;³¶ºñ°¡ ¸¹Àº
inertia effect
°ü¼ºÈ¿°ú !
infirmatory
(³í°ÅµîÀ»)¾àȽÃŰ´Â;¹«È¿·Î ÇÏ´Â
informal vote
(¿À½º,´ºÁú)¹«È¿ÅõÇ¥(¿ëÁö)
inoperative
ÀÛ¿ëÇÏÁö ¾Ê´Â;È¿·Â(È¿°ú)¾ø´Â
insulin
Àν¶¸°(ÃéÀå È£¸£¸ó,´ç´¢º´ÀÇ Æ¯È¿¾à)
integrase
(»ýÈ)ÀÎÅ×±×·¹À̽º(¼÷ÁÖ ¼¼±ÕÀÇ DNA¿¡ ÇÁ·ÎÆÄÁö(PROPHAGE)ÀÇ ÁÖÀÔÀ» Ã˸ÅÇÏ´Â È¿¼Ò
intensity
°·Ä;°Ý·Ä;¸Í·Ä;¼¼±â;°µµ(strength);È¿·Â;¸í¾Ï
inure
ÀÍÈ÷´Ù;´Ü·ÃÇÏ´Ù;(¹ý)È¿·ÂÀ» ¹ß»ýÇÏ´Ù;µµ¿òÀÌ µÇ´Ù
invalid
(Áõ°Å µîÀÌ)¹Ú¾àÇÑ °¡Ä¡¾ø´Â(¹ý)¹«È¿ÀÇ
invalidate
¹«È¿·Î ¸¸µé´Ù
invalidation
¹«È¿·Î ÇÔ;½ÇÈ¿
invalidity
¹«È¿
inventory recession
Àκ¥Å丮 ¸®¼¼¼Ç(Àç°í °ú´Ù·Î ÀÎÇÑ À¯È¿ ¼ö¿äÀÇ °¨Åð·Î »ý±â´Â °æ±â ÈÄÅð)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½